Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (1241-1250 of 3,162) with videos related to

Pageof 317
Sort By:
Diagnostic Microbiology and Infectious Disease|April 6, 2007
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC valuesRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|July 14, 2001
In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agentR N Jones, D J Biedenbach, D M Johnson, et al.
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)Daryl J Hoban, Douglas J Biedenbach, Alan H Mutnick, et al.
Human Genetics|June 20, 2002
An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndromeMaxim I Lutskiy, Lauren N Jones, Fred S Rosen, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2002
Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000Alan H Mutnick, Douglas J Biedenbach, John D Turnidge, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2011
JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strainsDavid J Farrell, Lisa C Liverman, Douglas J Biedenbach, et al.
Journal of the American Geriatrics Society|November 18, 2000
The protective effect of social engagement on mortality in long-term careD K Kiely, S E Simon, R N Jones, et al.
Occupational Medicine (Oxford, England)|February 13, 2020
UK military women: mental health, military service and occupational adjustmentN Jones, M Jones, N Greenberg, et al.
Journal of Cellular Biochemistry|April 7, 2006
Nuclease sensitive element binding protein 1 gene disruption results in early embryonic lethalityLin Fan, Stephen N Jones, Carolyn Padden, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 2005
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensJennifer M Streit, Helio S Sader, Thomas R Fritsche, et al.
Pageof 317

Showing results (1241-1250 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|April 6, 2007
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC valuesRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|July 14, 2001
In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agentR N Jones, D J Biedenbach, D M Johnson, et al.
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)Daryl J Hoban, Douglas J Biedenbach, Alan H Mutnick, et al.
Human Genetics|June 20, 2002
An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndromeMaxim I Lutskiy, Lauren N Jones, Fred S Rosen, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2002
Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000Alan H Mutnick, Douglas J Biedenbach, John D Turnidge, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2011
JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strainsDavid J Farrell, Lisa C Liverman, Douglas J Biedenbach, et al.
Journal of the American Geriatrics Society|November 18, 2000
The protective effect of social engagement on mortality in long-term careD K Kiely, S E Simon, R N Jones, et al.
Occupational Medicine (Oxford, England)|February 13, 2020
UK military women: mental health, military service and occupational adjustmentN Jones, M Jones, N Greenberg, et al.
Journal of Cellular Biochemistry|April 7, 2006
Nuclease sensitive element binding protein 1 gene disruption results in early embryonic lethalityLin Fan, Stephen N Jones, Carolyn Padden, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 2005
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogensJennifer M Streit, Helio S Sader, Thomas R Fritsche, et al.
Pageof 317